Project Number GC-2013722 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2017 View Full Project Details for De-risking the therapeutic opportunity of HDAC6 for neurodegenerative tauopathies Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) q. Epigenetic Regulators Researcher and Organization Principal Investigator Kranz, Janice Principal Investigator First Name Janice Principal Investigator Last Name Kranz Awardee Organization Eikonizo Therapeutics, Inc. Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $841,062 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
